DEA Delays MMJ Manufacturing of Marijuana Drug for Multiple Sclerosis and Huntington’s Disease Patients
DEA application process is being delayed for years for reasons unknown thus negatively impacting the progression of the drug development...
Day: March 13, 2022
Core One Labs Proceeds with Next Milestone Achievement: To Produce Psilocybin
Successful Breakthrough of Biosynthetic Psilocybin Production Method Progressing QuicklyVANCOUVER, British Columbia, March 12, 2022 (GLOBE NEWSWIRE) -- Core One Labs...